Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Multitarget antibacterial drugs: An effective strategy to combat bacterial resistance
J Feng, Y Zheng, W Ma, A Ihsan, H Hao… - Pharmacology & …, 2023 - Elsevier
The rise of antibiotic resistance and the decrease in the discovery of new antibiotics have
caused a global health crisis. Of particular concern is the fact that despite efforts to develop …
caused a global health crisis. Of particular concern is the fact that despite efforts to develop …
Dual inhibitors of HDAC and other epigenetic regulators: A novel strategy for cancer treatment
A significant advancement in the field of epigenetic drug discovery has been evidenced in
recent years. Epigenetic alterations are hereditary, nevertheless reversible variations to …
recent years. Epigenetic alterations are hereditary, nevertheless reversible variations to …
Are inhibitors of histone deacetylase 8 (HDAC8) effective in hematological cancers especially acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) …
Abstract Histone deacetylase 8 (HDAC8) aberrantly deacetylates histone and non-histone
proteins. These include structural maintenance of chromosome 3 (SMC3) cohesin protein …
proteins. These include structural maintenance of chromosome 3 (SMC3) cohesin protein …
The histone deacetylase family: structural features and application of combined computational methods
Histone deacetylases (HDACs) are crucial in gene transcription, removing acetyl groups
from histones. They also influence the deacetylation of non-histone proteins, contributing to …
from histones. They also influence the deacetylation of non-histone proteins, contributing to …
Design of Multi-Target drugs of HDACs and other Anti-Alzheimer related Targets: Current strategies and future prospects in Alzheimer's diseases therapy
Alzheimer disease (AD) is the most prevalent form of dementia that develops spontaneously
in the elderly. It's worth mentioning that as people age, the epigenetic profile of the central …
in the elderly. It's worth mentioning that as people age, the epigenetic profile of the central …
Asclepiadoideae subfamily (Apocynaceae): ethnopharmacology, biological activities and chemophenetics based on pregnane glycosides
TA de Souza, FSV Lins, J da Silva Lins, AF Alves… - Phytochemistry …, 2024 - Springer
Apocynaceae, one of the largest plant families with over 5.100 widely distributed species,
serves as a significant model for evolutionary and biochemical studies. Within this family …
serves as a significant model for evolutionary and biochemical studies. Within this family …
Discovery of Highly Potent and Orally Bioavailable Histone Deacetylase 3 Inhibitors as Immunomodulators and Enhancers of DNA-Damage Response in Cancer …
S Li, Z Hu, W Pan, H Wu, W Peng, Y Wu… - Journal of Medicinal …, 2025 - ACS Publications
Histone deacetylase 3 (HDAC3) is a well-established target for cancer therapy. Herein, we
developed LSQ-28 as a novel HDAC3 inhibitor, which exhibited high HDAC3 inhibitory …
developed LSQ-28 as a novel HDAC3 inhibitor, which exhibited high HDAC3 inhibitory …
Improving the Thrombocytopenia Adverse Reaction of Belinostat Using Human Serum Albumin Nanoparticles
JY Liu, CH Yen, YF Lin, YH Feng… - International Journal of …, 2024 - Taylor & Francis
Background Belinostat, a histone deacetylase inhibitor used for hematological cancer
treatments, however, it caused thrombocytopenia, poor solubility, and rapid clearance. To …
treatments, however, it caused thrombocytopenia, poor solubility, and rapid clearance. To …
Deacetylation of histones and non-histone proteins in inflammatory diseases and cancer therapeutic potential of histone deacetylase inhibitors
E Man, S Evran - Current Genomics, 2023 - benthamdirect.com
Epigenetic changes play an important role in the pathophysiology of autoimmune diseases
such as allergic asthma, multiple sclerosis, lung diseases, diabetes, cystic fibrosis …
such as allergic asthma, multiple sclerosis, lung diseases, diabetes, cystic fibrosis …
Synergistic strategies: histone deacetylase inhibitors and platinum-based drugs in cancer therapy
Introduction The synergistic combination of histone deacetylase inhibitors and platinum-
based medicines represents a promising therapeutic strategy to efficacy and overcome drug …
based medicines represents a promising therapeutic strategy to efficacy and overcome drug …